Abstract:
An innovative study at Robarts Research Institute provides early evidence that hospital MRI scanners can be used to detect distinct brain cell abnormalities that are predictors of multiple sclerosis (MS). In a preclinical study in rats with a disease similar to the human form, Robarts scientist Dr. Paula Foster used an injection of nano-particles of iron oxide, which exhibit magnetic qualities and can be detected by an MRI scanner.